Loading…
Loading…
EQUITY / NASDAQ · XNCM
Alzamend Neuro, Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗1.73 USD · 0%
Observed: Sep 30, 2026, 8:33 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
09/30/2026 · 1.73 USD · Volume 21,705
21 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
05/01/2026 – 07/31/2026 · Units
| Metric | 2027 / Quarter 1 | Prior year | Change |
|---|---|---|---|
| Cash and cash equivalents | 7,591,444 USD | — | — |
| Financing cash flow | 8,019,272 USD | — | — |
| Net income | -3,027,002 USD | — | — |
| Operating cash flow | -1,138,517 USD | — | — |
| Operating profit | -3,025,396 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2027 / Quarter 1ConsolidatedUnits · USD | 2026 / Quarter 1ConsolidatedUnits · USD | 2026 / Year endConsolidatedUnits · USD | 2026 / Year endConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 7,591,444 USD | 710,689 USD | 710,689 USD | — | 2,713,139 USD | — | — | 4,449,433 USD |
| Financing cash flowCash flow statement | 8,019,272 USD | — | 4,829,844 USD | — | — | 4,035,000 USD | — | — |
| Net incomeIncome statement | -3,027,002 USD | — | -8,772,382 USD | — | -2,198,991 USD | -5,902,433 USD | — | -1,000,758 USD |
| Operating cash flowCash flow statement | -1,138,517 USD | — | -8,067,813 USD | — | — | -5,270,519 USD | — | — |
| Operating profitIncome statement | -3,025,396 USD | — | -8,766,841 USD | — | -2,197,654 USD | -5,895,964 USD | — | -998,109 USD |
| Total assetsBalance sheet | 8,542,061 USD | 2,079,363 USD | 2,079,363 USD | — | 4,041,833 USD | — | — | 5,091,684 USD |
| Total equityBalance sheet | 5,802,680 USD | 733,211 USD | 733,211 USD | 2,200,000 USD | 2,184,505 USD | — | 4,374,196 USD | 4,374,196 USD |
| Total liabilitiesBalance sheet | 2,739,381 USD | 1,346,152 USD | 1,346,152 USD | — | 1,857,328 USD | — | — | 717,488 USD |
| Report source | Open report ↗ Published: 09/10/2026 | Open report ↗ Published: 09/10/2026 | Open report ↗ Published: 07/22/2026 | Open report ↗ Published: 07/22/2026 | Open report ↗ Published: 03/11/2026 | Open report ↗ Published: 03/11/2026 | Open report ↗ Published: 03/11/2026 | Open report ↗ Published: 12/09/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.